SZSE:301096 (China)
Â
Class A
Â¥
63.47
(-0.11%)
May 23
Business Description
Hangzhou Bio-Sincerity Pharma-Tech Co Ltd
ISIN : CNE1000056N5
Share Class Description:
SZSE:301096: Class ACompare
Compare
Traded in other countries / regions
301096.China IPO Date
2021-12-20Description
Hangzhou Bio-Sincerity Pharma-Tech Co Ltd is a pharmaceutical technology research and development company. The company's business covers drug discovery, pharmaceutical research, clinical research, and registration application.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.24 | |||||
| Equity-to-Asset | 0.72 | |||||
| Debt-to-Equity | 0.23 | |||||
| Debt-to-EBITDA | 2.02 | |||||
| Interest Coverage | 86.67 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 4.75 | |||||
| Beneish M-Score | -1.49 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 54.2 | |||||
| 3-Year EBITDA Growth Rate | 51.7 | |||||
| 3-Year EPS without NRI Growth Rate | 48.4 | |||||
| 3-Year FCF Growth Rate | -30.5 | |||||
| 3-Year Book Growth Rate | 80.6 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 26.17 | |||||
| 9-Day RSI | 30.2 | |||||
| 14-Day RSI | 35 | |||||
| 6-1 Month Momentum % | 2.81 | |||||
| 12-1 Month Momentum % | 8.41 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.73 | |||||
| Quick Ratio | 1.6 | |||||
| Cash Ratio | 0.82 | |||||
| Days Inventory | 94.48 | |||||
| Days Sales Outstanding | 69.98 | |||||
| Days Payable | 236.43 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.26 | |||||
| Dividend Payout Ratio | 0.28 | |||||
| 5-Year Yield-on-Cost % | 1.27 | |||||
| 3-Year Average Share Buyback Ratio | -10.3 | |||||
| Shareholder Yield % | -3.26 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 66.04 | |||||
| Operating Margin % | 29.79 | |||||
| Net Margin % | 26.74 | |||||
| FCF Margin % | -70.02 | |||||
| ROE % | 10.94 | |||||
| ROA % | 8.17 | |||||
| ROIC % | 12.8 | |||||
| ROC (Joel Greenblatt) % | 20.06 | |||||
| ROCE % | 11.34 | |||||
| Years of Profitability over Past 10-Year | 6 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 23.95 | |||||
| PE Ratio without NRI | 22.36 | |||||
| PEG Ratio | 0.42 | |||||
| PS Ratio | 6.4 | |||||
| PB Ratio | 2.52 | |||||
| Price-to-Tangible-Book | 2.61 | |||||
| EV-to-EBIT | 21.48 | |||||
| EV-to-EBITDA | 21.48 | |||||
| EV-to-Revenue | 6.31 | |||||
| EV-to-FCF | -9 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1.06 | |||||
| Price-to-Graham-Number | 1.61 | |||||
| Price-to-Net-Current-Asset-Value | 12 | |||||
| Earnings Yield (Greenblatt) % | 4.66 | |||||
| FCF Yield % | -10.86 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Hangzhou Bio-Sincerity Pharma-Tech Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 1,072.23 | ||
| EPS (TTM) (Â¥) | 2.65 | ||
| Beta | 0 | ||
| Volatility % | 26.13 | ||
| 14-Day RSI | 35 | ||
| 14-Day ATR (Â¥) | 2.54639 | ||
| 20-Day SMA (Â¥) | 68.0715 | ||
| 12-1 Month Momentum % | 8.41 | ||
| 52-Week Range (Â¥) | 51.01 - 77.78 | ||
| Shares Outstanding (Mil) | 108.92 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Hangzhou Bio-Sincerity Pharma-Tech Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Hangzhou Bio-Sincerity Pharma-Tech Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Hangzhou Bio-Sincerity Pharma-Tech Co Ltd Frequently Asked Questions
What is Hangzhou Bio-Sincerity Pharma-Tech Co Ltd(SZSE:301096)'s stock price today?
The current price of SZSE:301096 is ¥63.47. The 52 week high of SZSE:301096 is ¥77.78 and 52 week low is ¥51.01.
When is next earnings date of Hangzhou Bio-Sincerity Pharma-Tech Co Ltd(SZSE:301096)?
The next earnings date of Hangzhou Bio-Sincerity Pharma-Tech Co Ltd(SZSE:301096) is .
Does Hangzhou Bio-Sincerity Pharma-Tech Co Ltd(SZSE:301096) pay dividends? If so, how much?
The Dividend Yield %  of Hangzhou Bio-Sincerity Pharma-Tech Co Ltd(SZSE:301096) is 1.26% (As of Today), Highest Dividend Payout Ratio of Hangzhou Bio-Sincerity Pharma-Tech Co Ltd(SZSE:301096) was 0.38. The lowest was 0.28. And the median was 0.36. The  Forward Dividend Yield % of Hangzhou Bio-Sincerity Pharma-Tech Co Ltd(SZSE:301096) is 0%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers